Suprapubic catheter is a hollow flexible tube intended to create a passage between the urinary bladder and skin to drain urine from the bladder of the individual suffering from obstruction of normal urinary flow. Swelling of the prostate, traumatic disruption of urethra, congenital defects of the urinary tract, or obstructions of kidney stones passed into the urethra can block the normal urinary flow. Suprapubic catheterization refers to the placement of a drainage tube into the urinary bladder just above the pubic symphysis. This is typically performed for individuals who are unable to drain their bladder via the urethra. Suprapubic catheterization offers an alternative means to drain the urinary bladder when other methods are not clinically feasible, undesirable or impossible. This activity reviews the technique of suprapubic bladder catheterization, its indications, contraindications and role of the interprofessional team in the management of patients who are not able to void urine. The most common indication for suprapubic tube placement is for urinary retention when urethral catheterization is not feasible. This can include severe benign prostatic hyperplasia, false urethral passages, morbid obesity, urethral strictures, bladder neck contracture and genital malignancy. Urogenital trauma causing urethral disruption and severe damage are common indications. Suprapubic tube placement for the long-term diversion of urine in cases of neurogenic bladder is also sometimes indicated.
Market Dynamics
Increasing prevalence of kidney disorders such as kidney stone (Urolithiasis) is expected to drive the suprapubic catheter market growth. For instance, in May 2022, according to the data published by the National Center for Biotechnology Information, each year, more than 50,346 million people go to emergency rooms for kidney stone problems worldwide. It is estimated that one in ten people will have a kidney stone at some time in their lives. More than 1 in 7, that is 15% of U.S. adults or 37 million people, were estimated to have chronic kidney disease in the year 2021. Chronic Kidney Disease was more common in people aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%).
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Detailed Segmentation:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients